AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: PreserVision (Bausch + Lomb) (preservision.com)
This is a high-substance medical supplement site that successfully bridges the gap between consumer marketing and clinical rigor. It avoids the ‘snake oil’ traps of the industry by tethering every major efficacy claim to National Eye Institute studies and recent peer-reviewed literature.
Directly link the ‘America’s #1 AREDS Brand’ claim to the specific market research source or survey data in the footer to eliminate the minor ‘Claims without evidence’ penalty. Replace the ‘Protects, Nourishes, Boosts’ H3 headings with more descriptive technical titles like ‘Free Radical Neutralization’ or ‘Cellular Function Support.’ Ensure the NEI 10-year follow-on study results are summarized in a downloadable PDF for even higher proof density.
The site maintains a relatively high substance-to-fluff ratio. While headings like ‘Protects, Nourishes, Boosts’ utilize generic marketing power words, they are immediately anchored by specific technical details such as the ‘unique B-vitamin complex’ and the ‘NEI recommended AREDS2 nutrients.’ Unlike generic supplement sites, this text includes specific peer-reviewed citations, notably the Kotagiri SR, et al. study in Ophthalmol Ther (2022), providing a high degree of noun-heavy technical evidence.
AI does not see your layout — it sees your DOM. Get a Clinical Semantic Structure Diagnosis to reveal how your page is segmented, weighted, and interpreted.
There is virtually zero semantic drift between the homepage signal and the sub-page evidence. The homepage promises ‘clinically proven’ results and the ‘Most Advanced’ formula, and the Discover AREDS3 and Eyecare Professionals pages deliver on this with bioavailability data (OCUSorb) and comparisons to original formulations. The shift from consumer-facing lifestyle benefits to professional-facing clinical data (survey of 200 optometrists) is coherent and professionally managed.
Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.
The site avoids common trust theatre traps; while it lacks a verified third-party review widget (review_count is 0), it relies on institutional authority. The primary trust signals are ‘America’s #1 AREDS Brand’ and ‘NEI Collaboration,’ which are significant claims. However, the site provides a specific proof_links_count of 3 on the product pages, leading to actual clinical study summaries rather than just ‘As Seen On’ logos.
Proof density is high for this category. The site balances vague assertions like ‘Supports macular health’ with very specific data points like ‘2x more absorption of lutein’ and citations of specific journal articles (Ophthalmol Ther. 2022;11(4):1463-1477). This results in a proof-to-claim ratio that favors verifiable evidence over marketing air.
To review a full competitive diagnostic applied to an enterprise level technical SEO agency, including a direct comparison against Dejan, examine the complete executive audit. View the iPullRank Executive SEO Strategy Dashboard for a practical example of how perception gaps, value prop drift, and audience misalignment are surfaced in real audits.
The site does exhibit some industry clichés from the patterns_json, specifically ‘breakthrough innovation’ and ‘science-driven solutions.’ The value proposition is less susceptible to copy-pasting than competitors because it is fundamentally tied to the AREDS and AREDS2 clinical trials, which are specific historical events in ophthalmology. Boilerplate sections like ‘Why Choose PreserVision?’ are tempered by 20+ years of specific study references.
The authority is derived from the parent organization Bausch + Lomb and the National Eye Institute rather than individual named experts. Schema.org data is robust, utilizing Organization and DietarySupplement types with proper sameAs links to official social profiles. The technical implementation is professional, with a clean heading hierarchy and structured data that mirrors the site’s claim of being a market leader.
Performance claims regarding AMD risk reduction are highly regulated and the site carefully qualifies them with asterisks and FDA disclaimers. The site demonstrates performance through a 10-year follow-on study result (2022) rather than vague testimonials. There is no disconnect between the marketing tone and the clinical data provided on the professional sub-page.
Medical Devices, Pharma & Biotech BS: PreserVision (Bausch + Lomb) (preservision.com)
The content perfectly aligns with the Medical Devices and Pharma industry category, specifically the nutraceutical segment. It leverages high-stakes clinical terminology such as ‘AMD progression’ and ‘AREDS2 nutrients’ which are standard for therapeutic eye care.
Every retrieval error rooted in "wrong page surfaced" begins with one failure: unstable URL identity. Read the URL & Canonical Technical Guide to learn how consistent paths and canonical alignment preserve semantic cohesion.
“The score of 27 reflects a low BS level. The points mainly come from the 'Triple Action' marketing fluff and the high density of industry-standard cliches in the commodity fingerprint pillar. The technical authority and cross-page consistency are nearly perfect.”
Analysis Disclosure & Source Attribution
Snapshot Date: June 19, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at PreserVision (Bausch + Lomb) to view the most current version of their content and see directly what the company offers.